Tag: Pharmacology achievement award

🎓 Education

Dr. Liu earned his Ph.D. in Material Science and Engineering from South China University of Technology in 2021 under the supervision of Prof. Bo Zhou. His doctoral research was focused on rare earth luminescent materials and their applications in lighting and biomedicine. Before that, he completed his Master’s in Metallurgical Engineering from Jiangxi University of Science and Technology in 2018, where he studied advanced materials for various industrial applications. His academic journey began with a Bachelor’s in Chemical Engineering from Hubei Normal University in 2015. During his education, Dr. Liu developed a solid foundation in material science, which laid the groundwork for his later pioneering work in optical materials and nanotechnology. His research contributions have earned him accolades, and his educational background supports his deep understanding of material synthesis, properties, and their real-world applications.

💼 Experience

Dr. Liu currently serves as Associate Professor at Jiangxi University of Science and Technology, where he is involved in teaching and research on rare earth luminescent materials. Prior to this role, he worked as a Research Director for the National Rare Earth Functional Materials Innovation Center, focusing on rare earth luminescence and upconversion nanomaterials. Dr. Liu’s earlier work as a Lecturer at Jiangxi University further enriched his expertise in teaching and research. He is also actively involved in multiple editorial roles for prestigious journals, including Youth Editorial Board Member for Information & Functional Materials and Progress in Natural Science: Materials International. Additionally, Dr. Liu is a Peer Reviewer for numerous high-impact journals such as Adv Opt Mater and J Lumin. His vast experience in both academia and research has made him a valuable asset to the scientific community.

Honors & Awards 🏆🎓

Dr. Liu has received numerous prestigious awards and honors throughout his career. He is a candidate for the Young Elite Scientists Sponsorship Program by the China Association for Science and Technology (CAST), awarded in 2022. He has also been nominated for the Distinguished Young Scholars Foundation by the Department of Science and Technology of Jiangxi Province, an honor that recognizes young scholars with exceptional research potential. In addition to these recognitions, Dr. Liu is a candidate for the Far-sailing Program of JXAST, a program supported by Jiangxi Association for Science and Technology, highlighting his leadership in scientific innovation. He has also been honored as one of the Top 10 Technological Innovation Leaders of Ganxian District, reflecting his contributions to local technological advancements. These accolades signify Dr. Liu’s commitment to excellence in research and his growing influence in the material science community.

Research Focus 🔬⚡

Dr. Liu’s research primarily focuses on the controllable synthesis and optical property regulation of rare earth luminescent materials, such as LED phosphors and upconversion nanomaterials. His work explores innovative ways to enhance the optical and physical properties of these materials for a variety of applications, including lighting displays, biomedicine, and energy catalysis. He is particularly interested in nanostructure engineering, aiming to improve the efficiency and versatility of these materials in emerging technologies. Dr. Liu has made significant contributions to nanotechnology, particularly in the development of upconversion nanomaterials with applications in solar energy, biomedicine, and anti-counterfeiting. His research has expanded the practical application of rare earth materials, with a focus on improving the sustainability and performance of lighting technologies and energy systems.

Conclusion

Dr. Songbin Liu stands out as a highly deserving candidate for the Best Researcher Award due to his exceptional research contributions, leadership in the field of rare earth materials, and ongoing recognition as a rising star in material science. His academic rigor, impactful publications, and innovative approach to materials science make him an ideal recipient of this prestigious award. With continued growth in international collaborations and interdisciplinary applications, Dr. Liu has the potential to further shape the future of his field.

Publication Top Notes

Highly Regular, Uniform K₃ScF₆:Mn⁴⁺ Phosphors: Facile Synthesis, Microstructures, Photoluminescence Properties, and Application in Light-Emitting Diode

Authors: H. Ming, S. Liu, L. Liu, J. Peng, J. Fu, F. Du, X. Ye

Citations: 182

Year: 2018

Color Tunable Upconversion Luminescence, Multiple Temperature Sensing and Optical Heating Properties of Ba₃Y₄O₉: Er³⁺/Yb³⁺ Phosphors

Authors: S. Liu, H. Ming, J. Cui, S. Liu, W. You, X. Ye, Y. Yang, H. Nie, R. Wang

Citations: 179

Year: 2018

Controlling upconversion in emerging multilayer core–shell nanostructures: from fundamentals to frontier applications

Authors: S. Liu, L. Yan, J. Huang, Q. Zhang, B. Zhou

Citations: 167

Year: 2022

Intense and color-tunable upconversion luminescence of Er³⁺ doped and Er³⁺/Yb³⁺ co-doped Ba₃Lu₄O₉ phosphors

Authors: X. Ye, Y. Luo, S. Liu, D. Hou, W. You

Citations: 62

Year: 2017

Dynamic control of orthogonal upconversion in migratory core–shell nanostructure toward information security

Authors: J. Huang, L. Yan, S. Liu, N. Song, Q. Zhang, B. Zhou

Citations: 61

Year: 2021

Tri-channel photon emission of lanthanides in lithium-sublattice core-shell nanostructures for multiple anti-counterfeiting

Authors: S. Liu, L. Yan, Q. Li, J. Huang, L. Tao, B. Zhou

Citations: 56

Year: 2020

Optical multiplexing of upconversion in nanoparticles towards emerging applications

Authors: S. Liu, Z. An, B. Zhou

Citations: 52

Year: 2023

Investigation on the upconversion luminescence in Ho³⁺/Yb³⁺ co-doped Ba₃Sc₄O₉ phosphor

Authors: S. Liu, S. Liu, H. Ming, D. Hou, W. You

Citations: 41

Year: 2018

Tunable upconversion of holmium sublattice through interfacial energy transfer for anti-counterfeiting

Authors: R. Huang, S. Liu, J. Huang, H. Liu, Z. Hu, L. Tao, B. Zhou

Citations: 36

Year: 2021

Upconversion luminescence enhancement and temperature sensing behavior of F⁻ co-doped Ba₃Lu₄O₉: Er³⁺/Yb³⁺ phosphors

Authors: S. Liu, S. Liu, M. Zhou, X. Ye, D. Hou, W. You

Citations: 36

Year: 2017

Multiphoton ultraviolet upconversion through selectively controllable energy transfer in confined sensitizing sublattices towards improved solar photocatalysis

Authors: S. Liu, J. Huang, L. Yan, N. Song, P. Zhang, J. He, B. Zhou

Citations: 34

Year: 2021

Emmanouil Dedoulis | Business | Best Researcher Award

Posted on 09/12/202409/12/2024 by ScienceFather

Prof. Emmanouil Dedoulis | Business | Best Researcher Award

Professor in Accounting at Athens University of Economics and Business, Greece

Dr. Emmanouil Dedoulis is an accomplished academic with extensive research contributions in the field of accounting. He holds a Ph.D. from the University of Essex, UK, and has a remarkable portfolio of publications in leading journals, particularly in corporate governance, CSR reporting, and audit pricing. His work has been recognized with multiple teaching excellence awards, including those at Athens University of Economics and Business. Additionally, Dr. Dedoulis has actively contributed to academic communities through reviewing and organizing conferences.

Professional Profile

🎓 Education

Dr. Dedoulis earned a BA in Business Administration from the Athens University of Economics and Business (1992-1997). He furthered his studies with a Master’s in Accounting and Finance from the University of Essex (1997-1998). He completed his PhD in Accounting at Essex (1998-2004), where he focused on auditing and financial standards. His advanced education has solidified his position as a leading expert in accounting research and education.

💼 Experience

Dr. Dedoulis has had a robust academic career, teaching financial accounting at both undergraduate and postgraduate levels at AUEB since 2006. Additionally, he has worked as a certified auditor between 2005 and 2009, providing him with practical insights that complement his academic work. He has also been a reviewer for prominent journals in the field, contributing to the academic community’s understanding of accounting and auditing issues. Dr. Dedoulis’s diverse experience enhances his ability to deliver expert guidance to students and practitioners alike.

Honors & Awards 🏆🎓

Throughout his career, Dr. Dedoulis has received multiple recognitions for his scholarly contributions. He is a respected reviewer for leading journals such as Critical Perspectives on Accounting and Journal of Business Ethics. Additionally, his professional experience as a certified auditor and his involvement in the Committee of Accounting Books of the Ministry of Economy highlight his standing in both academic and professional circles. His continued influence in accounting research demonstrates his significant impact on the field.

Research Focus 🔬⚡

Dr. Dedoulis’s research spans auditing, ethics, and accounting standards, focusing on how these domains evolve and their societal implications. He explores the development of auditing practices, the role of ethics in accounting, and the intersection of accounting standards with inequalities. His work is published in top journals, reflecting his expertise in the intersection of finance, ethics, and institutional developments in accounting. His contributions aim to influence both policy and practice in accounting and auditing.

Conclusion

Dr. Dedoulis is a highly deserving candidate for the Best Researcher Award, given his sustained excellence in research, teaching, and academic service. His work continues to shape the field of accounting, particularly in corporate governance and social responsibility. The recognition of his contributions in leading journals and conferences highlights his scholarly influence. Moving forward, diversifying his research and engaging more with the public and industry would further elevate his impact.

Publication Top Notes

Corporate social responsibility reporting and organizational stigma: The case of “sin” industries
Authors: V Grougiou, E Dedoulis, S Leventis
Journal: Journal of Business Research
Citations: 323
Year: 2016

Corporate social responsibility and earnings management in US banks
Authors: V Grougiou, S Leventis, E Dedoulis, S Owusu-Ansah
Journal: Accounting Forum
Citations: 284
Year: 2014

The impact of religiosity on audit pricing
Authors: S Leventis, E Dedoulis, O Abdelsalam
Journal: Journal of Business Ethics
Citations: 126
Year: 2018

The impact of religiosity and corruption on CSR reporting: The case of US banks
Authors: A Chantziaras, E Dedoulis, V Grougiou, S Leventis
Journal: Journal of Business Research
Citations: 113
Year: 2020

Managing the European football industry: UEFA’s regulatory intervention and the impact on accounting quality
Authors: P Dimitropoulos, S Leventis, E Dedoulis
Journal: European Sport Management Quarterly
Citations: 110
Year: 2016

The cost of sin: The effect of social norms on audit pricing
Authors: S Leventis, I Hasan, E Dedoulis
Journal: International Review of Financial Analysis
Citations: 89
Year: 2013

Transplanting Anglo-American accounting oversight boards to a diverse institutional context
Authors: C Caramanis, E Dedoulis, S Leventis
Journal: Accounting, Organizations and Society
Citations: 72
Year: 2015

Corporate governance and institutions-A review and research agenda
Authors: A Zattoni, E Dedoulis, S Leventis, H Van Ees
Journal: Corporate Governance – An International Review
Citations: 62
Year: 2020

Equality, diversity and inclusion in accounting
Authors: O Kyriakidou, O Kyriacou, M Özbilgin, E Dedoulis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2016

Imperialism of influence and the state–profession relationship: The formation of the Greek auditing profession in the post-WWII era
Authors: E Dedoulis, C Caramanis
Journal: Critical Perspectives on Accounting
Citations: 60
Year: 2007

Mudit Kumar | Pharmacology | Best Researcher Award

Posted on 09/12/202409/12/2024 by ScienceFather

Mr. Mudit Kumar | Pharmacology | Best Researcher Award

Assistant professor at Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences Saifai Etawah Uttar pradesh, India

Mr. Mudit Kumar, an Assistant Professor in Pharmacology and Pharmacy at Uttar Pradesh University of Medical Sciences (UPUMS), has an impressive academic and research background. With a decade-long teaching career and multiple high-impact publications, patents, and awards, he has demonstrated consistent dedication to advancing pharmaceutical sciences. His contributions span research, innovation, and community involvement, making him a strong contender for the Best Researcher Award.

Professional Profile

🎓 Education

Mr. Mudit Kumar’s educational journey reflects his dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy (B.Pharm) in 2009 from Uttar Pradesh Technical University, establishing a solid foundation in pharmaceutical principles. Continuing his academic pursuits, he completed his Master of Pharmacy (M.Pharm) in 2012 from Bhagwant University, specializing in pharmacology. His postgraduate education equipped him with advanced knowledge of drug development, therapeutic mechanisms, and pharmacokinetics. Currently, Mr. Kumar is pursuing his PhD in Pharmacology, further delving into innovative pharmaceutical research. His academic progression demonstrates a commitment to continuous learning and specialization. Throughout his studies, he has shown a keen interest in pharmacological research, nanotechnology, and herbal medicine. His educational achievements have laid the groundwork for his successful teaching and research career, enabling him to contribute meaningfully to academia and the pharmaceutical industry.

💼 Experience

Mr. Mudit Kumar has over a decade of teaching experience in pharmacology and pharmacy. Since 2015, he has been serving as an Assistant Professor at the Uttar Pradesh University of Medical Sciences (UPUMS), Saifai, Etawah. In this role, he imparts knowledge in pharmaceutical sciences, mentors students, and contributes to curriculum development. Beyond teaching, Mr. Kumar actively engages in various institutional committees, including the Sports Committee, NIRF & NAAC Committee, and Career Guidance Committee, demonstrating his commitment to holistic academic growth. He has also played a role in maintaining student welfare as a member of the Anti-Ragging Squad. His experience extends to research and innovation, where he collaborates on projects leading to patents and publications. His professional journey underscores a blend of education, mentorship, and institutional service, contributing significantly to the academic and professional development of his students and colleagues.

Honors & Awards 🏆🎓

Mr. Mudit Kumar’s dedication to pharmaceutical sciences has earned him several prestigious accolades. In 2024, he received the Academic Excellence Award from the InSc Institute of Scholar for his outstanding contributions to research and teaching. The same year, he was recognized as the Best Pharmaceutical Scientist of the Year by the Preethvi Abhyuday Educators Association, highlighting his impactful work in pharmacology and drug development. These honors reflect his commitment to excellence, innovation, and advancing pharmaceutical education. Additionally, Mr. Kumar holds a lifetime professional membership with InSc and is an active member of the Association of Pharmaceutical Teachers of India (APTI) since 2023. His involvement in professional bodies and consistent recognition for academic and research achievements underline his stature as a leading figure in the pharmaceutical field. These awards serve as a testament to his dedication and influence in academia and research.

Research Focus 🔬⚡

Mr. Mudit Kumar’s research focuses on pharmacology, nanotechnology, and herbal medicine. He is particularly interested in the development of innovative drug delivery systems, such as lipid-polymer hybrid nanosystems and nano-lipid herbal formulations for diseases like diabetes and cancer. His work also explores the nephroprotective potential of natural extracts, wound healing properties of medicinal plants, and therapeutic approaches for Alzheimer’s disease. Additionally, Mr. Kumar investigates adverse drug reactions and the role of artificial intelligence in clinical trials. His research contributions include several peer-reviewed publications and three patents, showcasing his commitment to blending traditional medicine with modern pharmaceutical technologies. His interdisciplinary approach aims to enhance therapeutic efficacy and patient safety. Through his research, Mr. Kumar strives to bridge the gap between traditional herbal remedies and cutting-edge pharmaceutical innovations to address critical healthcare challenges.

Conclusion

Mr. Mudit Kumar’s extensive research portfolio, innovative patents, and commitment to education position him as a deserving candidate for the Best Researcher Award. His work not only advances pharmaceutical knowledge but also bridges the gap between research and real-world applications.

Publication Top Notes

📘 Callistemon citrinus (bottle brush) an important medicinal plant: a review of its traditional uses, phytoconstituents and pharmacological properties
Authors: N Sutar, R Sutar, M Kumar
Citations: 17
Year: 2014

🧪 Lipid–polymer hybrid nanosystems: a rational fusion for advanced therapeutic delivery
Authors: S Jain, M Kumar, P Kumar, J Verma, JM Rosenholm, KK Bansal, A Vaidya
Citations: 13
Year: 2023

🥒 Genetic analysis of yield traits in snake gourd (Trichosanthes anguina L.) genotypes
Authors: MJ Kumar, GK Rekha, CV Ramana, A Rajani, DR Suneetha
Citations: 2
Year: 2024

💊 Comparison between hypolipidemic effect of Lagenaria siceraria and lovastatin in hypercholesterolemic rats
Authors: A Senior, S Kumar, M Kumar
Citations: 2
Year: 2019

🏭 Sickness in small-scale industries in India
Authors: RR Saini, P Kumar, M Kumar
Citations: 2
Year: 2004

🍄 Current therapy and protective potential of medicinal mushroom Cordyceps militaris against Alzheimer’s disease
Authors: S Thakur, Y Singh, P Goyal, M Kumar
Citations: 1
Year: 2022

🧬 Analytical methods in the detection of proteins and peptides in tissue fluids and homogenates
Authors: S Jain, P Kumar, M Kumar, A Vaidya
Year: 2024

📚 Handbook of Blood Brain Barrier, Peptides and Amino Acids
Authors: Mudit Kumar, Dr. Pushpendra Kumar
Year: 2022

🌿 Anti-diabetic agent from nature
Author: Mudit Kumar
Year: 2018

📏 Common fixed point theorems satisfying a contractive condition of integral type in ε-chainable fuzzy metric space
Authors: RK Saini, B Singh, M Kumar, A Sharma
Year: N/A

🤖 AI in clinical trials and drug development: Challenges and potential advancements
Authors: D Gupta, P Wal, A Wal, KR Sribhavani, M Kumar, KC Panda, MC Sharma
Year: N/A

🩹 Evaluation of wound healing activity
Author: M Kumar
Year: N/A

🍃 Evaluation of Trichosanthes dioica Roxb. extract for nephroprotective potential
Authors: M Kumar, P Kumar, M Piplani
Year: N/A

Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Posted on 06/11/202406/11/2024 by ScienceFather

Assoc. Prof. Dr. Ismael Lares-Asseff | Pharmacology | Lifetime achievement Award

Assoc. Prof. Dr. Ismael Lares-Asseff, Instituto Politécnico Nacional, CIIDIR Durango, Mexico

Dr. Ismael Lares-Asseff, a prominent Mexican researcher, holds a degree in Medicine from UJED and a specialty in Pediatrics from IMAN and UNAM. He earned his Master’s and Ph.D. in Medical Sciences from UNAM, receiving the prestigious “Gabino Barreda Medal.” Mentored by renowned researcher Dr. Joaquín Cravioto, Dr. Lares founded Latin America’s first Clinical Pharmacokinetics Laboratory in 1982. His work spans pediatric pharmacokinetics, malnutrition, and pharmacogenetics among diverse ethnic groups, and he authored influential books like Clinical Pharmacology in Pediatrics and Pharmacogenomics in Latin America. With 190 publications, 671 citations, and numerous awards, he is a leader in personalized medicine.

Publication Profile

Background and Academic Achievements

Assoc. Prof. Dr. Ismael Lares-Asseff holds a distinguished background in medicine, earning degrees and accolades throughout his extensive career. With an MD from the Universidad Juárez del Estado de Durango (UJED), he specialized in Pediatrics through the Children’s Hospital of IMAN and the National Autonomous University of Mexico (UNAM). His academic journey culminated in a Master’s and Doctorate in Medical Sciences from UNAM, where he was awarded the “Gabino Barreda Medal” for his outstanding academic achievements.

Contributions to Pediatric Research and Clinical Pharmacokinetics

Under the mentorship of Dr. Joaquín Cravitoto, a globally respected figure in pediatric research, Dr. Lares-Asseff developed Mexico’s first Clinical Pharmacokinetics Laboratory in 1982. His early research primarily focused on understanding the impact of malnutrition on pediatric pharmacokinetics, producing findings published in prestigious journals. These works led to his internationally recognized book, Clinical Pharmacology in Pediatrics: Pharmacokinetics and Pharmacogenomics, awarded by the Mexican Academy of Pediatrics.

Conclusion

Assoc. Prof. Dr. Ismael Lares-Asseff is an ideal candidate for the Research for Lifetime Achievement Award. His contributions to pediatric pharmacology, pharmacogenetics, and personalized medicine embody a lifelong commitment to advancing medical science and patient care.

Publication Top Notes

🧬 Influence of Age, Gender, and BMI on IV Pharmacokinetics of Buprenorphine in Children Undergoing Orthopedic Surgery, Rivera-Espinosa, L., Vicencio-Rosas, E., et al., Dose-Response, 2024, 0 citations.
👨‍⚕️ Population Pharmacokinetics and Pharmacodynamics of L-asparaginase and Its Impact on Pancreatitis in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Drug and Chemical Toxicology, 2024, 0 citations.
💉 Nutritional Status as a Risk Factor for Doxorubicin Cardiotoxicity in Mexican Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Nutrition and Cancer, 2024, 0 citations.
🧪 Impact of SNPs and Nutrition on Doxorubicin Pharmacokinetics and Cardiotoxicity in Leukemia Patients, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Journal of Oncology Pharmacy Practice, 2023, 3 citations.
🌎 Barriers to Pharmacogenomics in Latin America and the Caribbean: Drug/Gene Pairs, Salas-Hernández, A., Galleguillos, M., et al., Frontiers in Pharmacology, 2023, 9 citations.
📝 Pharmacogenetics and Pharmacogenomics in Latin America: Perspectives, López-Cortés, A., Esperón, P., Lares-Asseff, I., et al., Frontiers in Pharmacology, 2023, 3 citations.
🐾 Silver Nanoparticles in Treating Distemper in Dogs: A Clinical Trial, Gastelum-Leyva, F., Pena-Jasso, A., et al., Viruses, 2022, 2 citations.
🔬 Mitochondrial Dysfunction Caused by Zinc Oxide Nanoparticles, Patrón-Romero, L., et al., Crystals, 2022, 16 citations.
🧬 Effect of Levetiracetam on Placental Transporter Gene Expression in Mice, Blanco-Castañeda, R., et al., Epilepsia, 2022, 0 citations.
❤️ Genetic Polymorphisms and Doxorubicin Cardiotoxicity in Children with ALL, Gándara-Mireles, J.A., Lares-Asseff, I., et al., Pharmacogenetics and Genomics, 2021, 8 citations.

Shubham Sharma | Pharmacology | Best Researcher Award

Posted on 18/10/202418/10/2024 by ScienceFather

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. 💻🔬💊⚡

Publication Profile

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) 🎓, where they conducted research under the guidance of Andrew A. Peterson 🧑‍🔬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) 🛠️. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research 🌱📘.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) 🧑‍🔬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling 💊. They contributed to the success of Zavegepant (Zavzpret™) and Rimegepant (Nurtec™) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science 🔬💻.

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) 🧪. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 🧑‍🏫. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎤. Their work spans computational modeling and applied research in materials science and electrocatalysis ⚛️.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) ⚡️🔋. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals 💊 and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems 🌍🔬, emphasizing electrochemical stability and performance improvement in energy devices.

Publication Top Notes

Anisotropic Strain Tuning of L1₀ Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Hua Jin | Pharmacology | Women Researcher Award

Posted on 23/09/202423/09/2024 by ScienceFather

Assoc Prof Dr. Hua Jin | Pharmacology | Women Researcher Award

Assoc Prof Dr. Hua Jin, Guangdong Medical University, China

Assoc. Prof. Dr. Hua Jin is an Associate Professor at Guangdong Medical University, Dongguan, China, specializing in nanochemistry, bionanomaterials, and drug delivery systems. He holds a PhD from Jinan University, China, and completed postdoctoral fellowships at Northwestern University and the University of Illinois at Chicago. Dr. Jin has published over 50 SCI papers with an H-index of 34, and holds multiple international and Chinese patents. His research primarily focuses on nanoparticle-based therapies for lung injuries and cancer. Notable publications include works in J Tissue Eng and Biomaterials Science.

Publication profile

“Silymarin”, a promising pharmacological agent for treatment of diseases

Education

Assoc. Prof. Dr. Hua Jin earned his Ph.D. in Nanochemistry and Bionanomaterials from Jinan University, Guangzhou, China, from September 2009 to July 2013, graduating in the top 5% of his class. Prior to that, he completed his M.Eng. in Inorganic Chemistry at the same institution from September 2006 to July 2009, also achieving a top 5% ranking. His strong academic background has laid a solid foundation for his innovative research in the fields of chemistry and nanotechnology. 🌟🔬✨

Work Experience

Assoc. Prof. Dr. Hua Jin has been an Associate Professor at the College of Medicine, Guangdong Medical University, since September 2018. He brings a wealth of research experience from his postdoctoral fellowships in the United States. From March 2017 to July 2018, he worked at Northwestern University in the Department of Lung Injury and Vascular Disease. Prior to that, from November 2013 to March 2017, he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois at Chicago. His diverse background enriches his contributions to medical research and education. 🌟🔬

Research Achievements

Assoc. Prof. Dr. Hua Jin has made remarkable contributions to research, publishing 50 papers in prestigious SCI journals, showcasing his expertise in his field. His research has garnered significant recognition, with an impressive H-index of 34, reflecting the impactful nature of his work. Dr. Jin also holds two international patents in Australia and three patents in China, highlighting his innovative contributions to science and technology. His achievements demonstrate a commitment to advancing knowledge and pushing the boundaries of research and development. 🌍📚💡

Publication Top Notes

Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury (2024) – [Cited by: 2] 🔬
Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation (2021) – [Cited by: 15] 📈
Berberine-Loaded Biomimetic Nanoparticles Attenuate Inflammation of Experimental Allergic Asthma via Enhancing IL-12 Expression (2021) – [Cited by: 10] 🌱
Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway (2021) – [Cited by: 8] 🥇
GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy (2021) – [Cited by: 5] 💊
Nasal Delivery of Hesperidin/Chitosan Nanoparticles Suppresses Cytokine Storm Syndrome in a Mouse Model of Acute Lung Injury (2021) – [Cited by: 3] 🐭
Peptide-Decorated Supramolecules for Subcellular Targeted Cancer Therapy: Recent Advances (2020) – [Cited by: 20] 📚
Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli (2020) – [Cited by: 12] 🦠
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis (2020) – [Cited by: 18] 🎯
EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy (2017) – [Cited by: 6] 🌼

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 17/08/202417/08/2024 by ScienceFather

Marzieh Rashedinia | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assoc Prof Dr Marzieh Rashedinia, Shiraz university of medical sciences, Iran

Based on the provided information, Assoc. Prof. Dr. Marzieh Rashedinia appears to be a strong candidate for the Best Researcher Award. Here’s a summary of her qualifications and contributions:

Publication profile

google scholar

Education

Ph.D. in Toxicology (2013), School of Pharmacy, Mashhad University of Medical Sciences, Iran.
M.Sc. in Toxicology (2009), School of Pharmacy, Shiraz University of Medical Sciences, Iran.
B.Sc. in Cell and Molecular Biology (2005), School of Sciences, Shiraz University, Iran.

Research Focus

Ph.D. Thesis: Evaluation of neuroprotective effects of Crocin on Acrolein-induced neurotoxicity in rats.
M.Sc. Thesis: The effect of ATP supplier compounds on Zinc phosphide toxicity in HepG2 Cells.

Research Techniques and Experiences

Cell culture, Toxicology screening tests, Animal behavior testing, Western blotting, Proteomics, Real-Time PCR, Immunoprecipitation, HPLC, In vivo and in vitro toxicity testing, Food contaminant analysis, Cell and molecular mechanisms of toxicity.

Notable Publications

“Silymarin: A promising pharmacological agent for treatment of diseases” – Iranian Journal of Basic Medical Sciences, 2011.
“Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin” – Toxicology and Industrial Health, 2015.
“Effects of sodium benzoate on learning, memory, and oxidative stress in mice” – Journal of Biochemical and Molecular Toxicology, 2018.
“Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis” – Human & Experimental Toxicology, 2016.

Abstracts and Congress Presentations

Syringic acid effects on oxidative stress in diabetic rats – 3rd World Congress and Expo on Traditional and Alternative Medicine, Berlin, 2019.
Syringic acid for renal oxidative stress management – 9th World Congress on Targeting Mitochondria, Berlin, 2018.
Glycyrrhizic acid modulates aluminium-induced oxidative stress – 6th National Congress on Medical Plants, Tehran, 2017.

Summary

Assoc. Prof. Dr. Marzieh Rashedinia has made significant contributions to the field of toxicology through her research on neuroprotection, oxidative stress, and food contaminants. Her extensive experience with advanced research techniques and impactful publications underlines her suitability for the Best Researcher Award.

Publication top notes

Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin

Effects of sodium benzoate, a commonly used food preservative, on learning, memory, and oxidative stress in brain of mice

Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis

Antioxidant activity of Pistacia vera fruits, leaves and gum extracts

Design and development of vitamin C-encapsulated proliposome with improved in-vitro and ex-vivo antioxidant efficacy

Vortex-assisted dispersive liquid-liquid microextraction based on hydrophobic deep eutectic solvent for the simultaneous identification of eight synthetic dyes in jellies and …

Neuroprotective effect of syringic acid by modulation of oxidative stress and mitochondrial mass in diabetic rats

Ellagic acid improves muscle dysfunction in cuprizone-induced demyelinated mice via mitochondrial Sirt3 regulation

Effect of sodium benzoate on liver and kidney lipid peroxidation and antioxidant enzymes in mice

Divya Jain | Pharmacology Award | Women Researcher Award

Posted on 08/07/202408/07/2024 by ScienceFather

Dr. Divya Jain | Pharmacology Award | Women Researcher Award

Dr. Divya Jain, Uttaranchal University, India

Dr. Divya Jain is an accomplished microbiologist, holding a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She currently serves as an Assistant Professor at Uttaranchal University, Dehradun, bringing extensive expertise in microbiology to the Department of Microbiology. Her previous roles include an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology in Chandigarh. Dr. Jain also completed a notable internship in content and academic writing with The Applied Biology & Chemistry Journal. 📚🔬✨

Publication profile

🎓 Education

Dr. Divya Jain holds a Ph.D. in Microbiology from Banasthali Vidyapith, Rajasthan (2023), an M.Sc. in Microbiology from Graphic Era University, Dehradun (2018), and a B.Sc. in Biotechnology from Banasthali Vidyapith (2016). She completed her high school education in PCB from S.D.R.R Public School, Shamli (2013). 📘🔬

🏢 Work Experience

Currently an Assistant Professor at Uttaranchal University, Dehradun, Dr. Jain also served as an Associate Research Fellow at the Integrative Centre for Research & Innovation in Biology, Chandigarh. 📚🔬

🏅 Certificates and Awards

Dr. Jain has earned several accolades, including the Innovative Article Award and the Excellence in Research Award. She has also completed certificate courses in microbiology, forensic science, and RJ-Ing. 🏆📜

Research Focus 🔬🌍

Dr. Divya Jain’s research is primarily focused on microbiology, environmental science, and pharmacology. Her work includes studying microbial pollution, particularly coliform bacteria, and their environmental impact. She has also contributed significantly to sustainable agriculture through research on plant growth-promoting microorganisms and mycorrhiza. Dr. Jain explores the pharmacological applications of natural compounds, such as propolis and medicinal plants, for cancer therapy and liver protection. Her research extends to evaluating potential inhibitors for SARS-CoV-2 and other viral infections, emphasizing bioactive compounds from natural sources. Her multifaceted research underscores her dedication to addressing critical global health and environmental challenges. 🌱🧬🧪

Publication Top Notes

“Microbial pollution of water with special reference to coliform bacteria and their nexus with environment” 🌊🦠 (110 citations, 2021)
S Some, R Mondal, D Mitra, D Jain, D Verma, S Das
Energy Nexus 1, 100008
“Role of mycorrhiza and its associated bacteria on plant growth promotion and nutrient management in sustainable agriculture” 🌱🔬 (90 citations, 2020)
D Mitra, N Uniyal, P Panneerselvam, A Senapati, AN Ganeshamurthy
International Journal of Life Sciences and Applied Sciences 1 (1), 1-1
“Propolis: An update on its chemistry and pharmacological applications” 🍯⚗️ (73 citations, 2022)
R Hossain, C Quispe, RA Khan, ASM Saikat, P Ray, D Ongalbek, …
Chinese medicine 17 (1), 100
“Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis” 🚬🔬 (53 citations, 2021)
D Jain, P Chaudhary, N Varshney, KS Bin Razzak, D Verma, …
Journal of Oncology 2021 (1), 5905357
“Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PLpro and Mpro/3CLpro: molecular docking and simulation studies of three pertinent medicinal plant natural components” 🧬🌿 (44 citations, 2021)
D Verma, D Mitra, M Paul, P Chaudhary, A Kamboj, H Thatoi, P Janmeda, …
Current Research in Pharmacology and Drug Discovery 2, 100038
“Biosynthesis of secondary metabolites based on the regulation of microRNAs” 🧬🧪 (33 citations, 2022)
R Hossain, C Quispe, ASM Saikat, D Jain, A Habib, P Janmeda, MT Islam, …
BioMed Research International 2022 (1), 9349897
“Hepatoprotective activity of medicinal plants: A mini review” 🌿🛡️ (29 citations, 2020)
D Jain, P Chaudhary, A Kotnala, R Hossain, K Bisht, MN Hossain
Journal of Medicinal Plants Studies 8 (5), 183-188
“Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway” 💤🍊 (25 citations, 2021)
R Hossain, K Al-Khafaji, RA Khan, C Sarkar, MS Islam, D Dey, D Jain, …
Pharmaceuticals 14 (8), 721
“Anticancer effects of acteoside: Mechanistic insights and therapeutic status” 🧬🎗️ (22 citations, 2022)
RA Khan, R Hossain, P Roy, D Jain, ASM Saikat, APR Shuvo, M Akram, …
European Journal of Pharmacology 916, 174699
“Carcinogenic effects of N-nitroso compounds in environment” 🚫🦠 (22 citations, 2020)
D Jain, P Chaudhary, N Varshney, P Janmeda
Environment Conservation Journal 21 (3), 25-41

Sihe Zhang | Pharmacology | Best Researcher Award

Posted on 19/06/202419/06/2024 by ScienceFather

Prof Sihe Zhang | Pharmacology | Best Researcher Award

Professor at Nankai University, China

Si-he Zhang is a distinguished cell biologist and professor at Nankai University, China. He earned his PhD in Cell Biology from the Fourth Military Medical University and has held various academic positions including Associate Professor at Lund University Hospital, Sweden. His research focuses on cancer biology, particularly in developing targeted therapies using antibodies and nanoparticle-based drug delivery systems. Zhang has authored numerous influential publications and holds several key patents in the field. He has received prestigious awards, including the Chinese Outstanding Patented Invention Gold Award and the National Prize for Progress in Science & Technology. Zhang also serves on several scholarly committees and as a consultant for leading biopharmaceutical companies in China.

Profile